Rapt Therapeutics downgraded to Underweight from Neutral at JPMorgan
The Fly

Rapt Therapeutics downgraded to Underweight from Neutral at JPMorgan

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App